Rectal Cancer: Management Trends and Changes. Concepts for Gastroenterologists and Surgeons
DOI:
https://doi.org/10.22516/25007440.828Keywords:
Rectum, Neoplasms of the rectum, Proctectomy, Staging of neoplasms, chemotherapy, RadiotherapyAbstract
Rectal cancer is the third most frequent cancer in Colombia and constitutes a diagnostic and therapeutic challenge for gastroenterologists, surgeons, and oncologists. Diagnostic evaluation and the study of its locoregional and systemic extension have been modified by new imaging methods, enabling an accurate view of anatomical structures that could not be easily examined before. The availability of these new tools in disease staging has significantly impacted therapeutic decisions and the choice of a specific treatment path for each patient, rationalizing the use of neoadjuvant therapies and the performance of surgery with correct anatomical criteria. The preceding has been essential to achieving the best outcomes with the least associated postoperative morbidity. This article will review and explain in detail the most recent changes and up-to-date recommendations for managing rectal cancer.
Downloads
References
Situación del cáncer de colon y recto en Colombia 2018 [Internet]. Fondo Colombiano de Enfermedades de Alto Costo [consultado el 17 de agosto de 2020]. Disponible en: https://cuentadealtocosto.org/site/publicaciones/fact-sheet-situacion-del-cancer-de-colon-y-recto-en-colombia-2018/
Dekker E, Tanis PJ, Vleugels JL, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467-80. https://doi.org/10.1016/S0140-6736(19)32319-0
Rectal cancer version 1 [Internet]. National Comprehensive Cancer Network; 2021 [consultado el 1 de agosto de 2021]. Disponible en: https://www.nccn.org/patients/guidelines/content/PDF/rectal-patient.pdf
Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, et al. Rectal cancer: ESMO clinical practice guidelines. Ann Oncol. 2017;28(4):iv22-iv40. https://doi.org/10.1093/annonc/mdx224
Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731-40. https://doi.org/10.1056/NEJMoa040694
MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology. 2007;243(1):132-9. https://doi.org/10.1148/radiol.2431051825
Patel A, Green N, Sarmah P, Langman G, Chandrakumaran K, Youssef H. The clinical significance of a pathologically positive lymph node at the circumferential resection margin in rectal cancer. Tech Coloproctol. 2019;23(2):151-9. https://doi.org/10.1007/s10151-019-01947-6
Habr-Gama A, Pérez RO, Wynn G, Marks J, Kessler H, Gama-Rodrigues J. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: Characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum. 2010;53(12):1692-8. https://doi.org/10.1007/DCR.0b013e3181f42b89
Perez RO, Habr-Gama A, São Julião GP, Lynn PB, Sabbagh C, Proscurshim I, et al. Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging. Tech Coloproctol. 2014;18(8):699-708. https://doi.org/10.1007/s10151-013-1113-9.
Habr-Gama A, São Julião GP, Fernandez LM, Vailati BB, Andrade A, Araújo SE, et al. Achieving a complete clinical response after neoadjuvant chemoradiation that does not require surgical resection: It may take longer than you think! Dis Colon Rectum. 2019;62(7):802-8. https://doi.org/10.1097/DCR.0000000000001338
D’Souza N, de Neree tot Babberich MP, d’Hoore A, Tiret E, Xynos E, Beets-Tan RG, et al. Definition of the rectum. Ann Surg. 2019;270(6):955-9. https://doi.org/10.1097/SLA.0000000000003251
Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ. MRI of rectal cancer: Tumor staging, imaging techniques, and management. RadioGraphics. 2019;39(2):367-87. https://doi.org/10.1148/rg.2019180114
Perez RO, Habr-Gama A, São Julião GP, Gama-Rodrigues J, Sousa AHS, Campos FG, et al. Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: Do all patients benefit from waiting longer than 6 weeks? Int J Radiat Oncol Biol Phys. 2012;84(5):1159-65. https://doi.org/10.1016/j.ijrobp.2012.01.096
Ortega CD, Pérez RO. Role of magnetic resonance imaging in organ-preserving strategies for the management of patients with rectal cancer. Insights Imaging. 2019;10(1):59. https://doi.org/10.1186/s13244-019-0742-6
Perez RO, Habr-Gama A, São Julião GP, Proscurshim I, Neto AS, Gama-Rodrigues J. Transanal endoscopic microsurgery for residual rectal cancer after neoadjuvant chemoradiation therapy is associated with significant immediate pain and hospital readmission rates. Dis Colon Rectum. 2011;54(5):545-51. https://doi.org/10.1007/DCR.0b013e3182083b84
Perez RO, Habr-Gama A, São Julião GP, Proscurshim I, Fernandez LM, de Azevedo RU, et al. Transanal endoscopic microsurgery (TEM) following neoadjuvant chemoradiation for rectal cancer: Outcomes of salvage resection for local recurrence. Ann Surg Oncol. 2015;23(4):1143-8. https://doi.org/10.1245/s10434-015-4977-2
Habr-Gama A, Sabbaga J, Gama-Rodrigues J, São Julião GP, Proscurshim I, Bailão Aguilar P, et al. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer. Dis Colon Rectum. 2013;56(10):1109-17. https://doi.org/10.1097/DCR.0b013e3182a25c4e
Habr-Gama A, Perez RO, São Julião GP, Proscurshim I, Fernandez LM, Figueiredo MN, et al. Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen. Radiat Oncol. 2016;11:24. https://doi.org/10.1186/s13014-016-0598-6
Garcia-Aguilar J, Patil S, Kim JK, Yuval JB, Thompson H, Verheij F, et al. Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial. J Clin Oncol. 2020;38(15):4008. https://doi.org/10.1200/jco.2020.38.15_suppl.4008
Habr-Gama A, São Julião GP, Vailati BB, Sabbaga J, Aguilar PB, Fernandez LM, et al. Organ preservation in CT2N0 rectal cancer after neoadjuvant chemoradiation therapy. Ann Surg. 2019;269(1):102-7. https://doi.org/10.1097/SLA.0000000000002447
Smith FML, Ahad A, Perez RO, Marks J, Bujko K, Heald RJ. Local excision techniques for rectal cancer after Neoadjuvant chemoradiotherapy: What are we doing? Dis Colon Rectum. 2017;60(2):228-39. https://doi.org/10.1097/DCR.0000000000000749
van der Valk MJM, Marijnen CAM, van Etten B, Dijkstra EA, Hilling DE, Kranenbarg EMK, et al. Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial. Radiother Oncol. 2020;147:75-83. https://doi.org/10.1016/j.radonc.2020.03.011
Yuval JB, Thompson HM, Garcia-Aguilar J. Organ preservation in rectal cancer. J Gastrointest Surg. 2020;24(8):1880-8. https://doi.org/10.1007/s11605-020-04583-w
Knol J, Keller DS. Total mesorectal excision technique - Past, present, and future. Clin Colon Rectal Surg. 2020;33(3):134-43. https://doi.org/10.1055/s-0039-3402776
Sands D, Wexner SD. Transanal total mesorectal excision. Clin Colon Rectal Surg. 2020;33(3):111-2. https://doi.org/10.1055/s-0039-3402775
Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, et al. Incidence and risk factors for anastomotic failure in 1594 patients treated BY transanal total mesorectal excision. Ann Surg. 2019;269(4):700-11. https://doi.org/10.1097/SLA.0000000000002653
Oostendorp SE, Belgers HJ, Bootsma BT, Hol JC, Belt EJ, Bleeker W, et al. Locoregional recurrences after transanal total mesorectal excision of rectal cancer during implementation. Br J Surg. 2020;107(9):1211-20. https://doi.org/10.1002/bjs.11525
Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, et al. Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: Results of the multicenter lateral node study of patients with low Ct3/4 rectal cancer. J Clin Oncol. 2019;37(1):33-43. https://doi.org/10.1200/JCO.18.00032
Protocol for the examination of excisional biopsy specimens from patients with primary carcinoma of the colon and rectum [Internet]. College of American Pathologists [consultado el 22 de agosto de 2021]. Disponible en: https://documents.cap.org/protocols/cp-gilower-colonrectum-biopsy-20-4100.pdf
Salem ME, Puccini A, Tie J. Redefining colorectal cancer by tumor biology. Am Soc Clin Oncol Educ Book. 2020;(40):147-59. https://doi.org/10.1200/EDBK_279867
Downloads
Published
How to Cite
Issue
Section
License
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
